| Ontology | CARD's Antibiotic Resistance Ontology |
| Accession | ARO:3007138 |
| Synonym(s) | 1-{(2r)-2-(Dihydroxyboranyl)-2-[(Thiophen-2-Ylacetyl)amino]ethyl}-1h-1,2,3-Triazole-4-Carboxylic Acid |
| Definition | S02030 is an experimental metallo-beta-lactamase inhibitor that exhibits activity against MOX-1. |
| SMILES | N/A |
| PubChem | 71519576 |
| AMR Gene Family | MOX beta-lactamase |
| Drug Class | penicillin beta-lactam, cephalosporin |
| Resistance Mechanism | antibiotic inactivation |
| Classification | 20 ontology terms | Show + process or component of antibiotic biology or chemistry + mechanism of antibiotic resistance + determinant of antibiotic resistance + antibiotic inactivation [Resistance Mechanism] + antibiotic inactivation enzyme + hydrolysis of antibiotic conferring resistance + hydrolysis of beta-lactam antibiotic by serine beta-lactamase + beta-lactamase + class C beta-lactamase + antibiotic molecule + resistance-modifying agents + inhibitor of antibiotic resistance mechanism + CMY-LAT-MOX beta-lactamase + beta-lactam antibiotic + CMY-MOX beta-lactamase + beta-lactamase inhibitor + penicillin beta-lactam [Drug Class] + cephalosporin [Drug Class] + metallo-beta-lactamase inhibitor + MOX beta-lactamase [AMR Gene Family] |
| Parent Term(s) | 2 ontology terms | Show |
| Publications | Ishikawa T, et al. 2021. Front Microbiol 12:720036 Insights Into the Inhibition of MOX-1 β-Lactamase by S02030, a Boronic Acid Transition State Inhibitor. (PMID 34970229) |
| Curator | Description | Most Recent Edit |
|---|